KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Gains from Sales and Divestitures (2016 - 2024)

Historic Gains from Sales and Divestitures for Zimmer Biomet Holdings (ZBH) over the last 13 years, with Q4 2024 value amounting to $405000.0.

  • Zimmer Biomet Holdings' Gains from Sales and Divestitures rose 5283.02% to $405000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $405000.0, marking a year-over-year increase of 5283.02%. This contributed to the annual value of $405000.0 for FY2024, which is 5283.02% up from last year.
  • Per Zimmer Biomet Holdings' latest filing, its Gains from Sales and Divestitures stood at $405000.0 for Q4 2024, which was up 5283.02% from $265000.0 recorded in Q4 2023.
  • Zimmer Biomet Holdings' Gains from Sales and Divestitures' 5-year high stood at $405000.0 during Q4 2024, with a 5-year trough of $168000.0 in Q4 2022.
  • Over the past 5 years, Zimmer Biomet Holdings' median Gains from Sales and Divestitures value was $265000.0 (recorded in 2023), while the average stood at $271600.0.
  • As far as peak fluctuations go, Zimmer Biomet Holdings' Gains from Sales and Divestitures crashed by 2970.71% in 2022, and later surged by 5773.81% in 2023.
  • Quarter analysis of 5 years shows Zimmer Biomet Holdings' Gains from Sales and Divestitures stood at $281000.0 in 2020, then fell by 14.95% to $239000.0 in 2021, then decreased by 29.71% to $168000.0 in 2022, then skyrocketed by 57.74% to $265000.0 in 2023, then skyrocketed by 52.83% to $405000.0 in 2024.
  • Its Gains from Sales and Divestitures was $405000.0 in Q4 2024, compared to $265000.0 in Q4 2023 and $168000.0 in Q4 2022.